Vontobel Holding Ltd. Harmony Biosciences Holdings, Inc. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$29.93 - $35.06 $107,748 - $126,216	-3,600 Reduced 33.96%	7,000 $235,000
Q4 2023 Jun 03, 2024	BUY	$19.2 - $33.78 $69,120 - $121,608	3,600 Added 51.43%	10,600 $342,000
Q4 2023 Jan 29, 2024	BUY	$19.2 - $33.78 $69,120 - $121,608	3,600 Added 51.43%	10,600 $342,000
Q3 2023 Oct 10, 2023	BUY	$31.89 - $39.03 $223,230 - $273,210	7,000 New	7,000 $229,000
Q1 2021 May 11, 2021	BUY	$27.56 - $40.37 $275,600 - $403,700	10,000 New	10,000 $330,000

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.94B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.